Poseida Therapeutics Inc (PSTX)
9.49
+0.01
(+0.11%)
USD |
NASDAQ |
Dec 24, 16:00
Poseida Therapeutics Total Assets (Quarterly): 293.58M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Galectin Therapeutics Inc | 28.97M |
| Revance Therapeutics Inc | 461.56M |
| Sage Therapeutics Inc | 622.43M |
| Alector Inc | 516.02M |
| Phathom Pharmaceuticals Inc | 387.04M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 206.37M |
| Shareholders Equity (Quarterly) | 87.21M |
| Debt to Equity Ratio | 0.6755 |
| Current Ratio | 3.203 |
| Net Debt Paydown Yield | -0.04% |